<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 27.5: Complex Comorbidity: Dual Diagnosis & Clinical Nuance</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE theme for Advanced Specialty Applications */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #daeaff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Data Tables */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
            line-height: 1.6;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 30px 35px;
            margin-top: 45px;
            border-radius: 16px;
            color: white;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0 0 20px 0;
            font-size: 18px;
            text-transform: uppercase;
            letter-spacing: 1px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .takeaways-box ul {
            margin: 0;
            padding-left: 20px;
        }

        .takeaways-box li {
            margin-bottom: 12px;
            font-size: 16px;
            color: rgba(255, 255, 255, 0.9);
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #f9fafb;
            border-radius: 12px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #374151;
            font-size: 16px;
        }

        .ref-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .ref-list li {
            font-size: 13px;
            color: #6b7280;
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.8;
        }

        .copyright {
            color: #888;
            font-size: 13px;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Standard.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">Lesson 5: Complex Comorbidity: Dual Diagnosis & Clinical Nuance</h1>
            <div class="lesson-meta">
                <span class="meta-item">45 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#differential"><span class="section-num">1</span>The Diagnostic Maze</a></li>
                <li><a href="#sud"><span class="section-num">2</span>Substance Use Disorders (SUD)</a></li>
                <li><a href="#eating-disorders"><span class="section-num">3</span>EDs and OCD Intersections</a></li>
                <li><a href="#polypharmacy"><span class="section-num">4</span>Atypical Pharmacological Responses</a></li>
                <li><a href="#overshadowing"><span class="section-num">5</span>Diagnostic Overshadowing</a></li>
                <li><a href="#collaboration"><span class="section-num">6</span>Multidisciplinary Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the differential diagnostic criteria between Autism/ADHD and Personality Disorders or C-PTSD.</li>
                <li>Analyze the unique presentation of Substance Use Disorders in neurodivergent populations and the "self-medication" hypothesis.</li>
                <li>Identify the clinical nuances of ARFID and restrictive eating patterns versus traditional Anorexia Nervosa.</li>
                <li>Evaluate the risks of polypharmacy and recognize atypical reactions to standard psychiatric medications.</li>
                <li>Develop strategies for effective advocacy within multidisciplinary medical teams to prevent diagnostic overshadowing.</li>
            </ul>
        </div>

        <div class="key-terms-box">
            <p class="box-label">Core Clinical Concepts</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Diagnostic Overshadowing</p>
                    <p class="definition">The tendency for clinicians to attribute all of a patient's symptoms to a pre-existing psychiatric diagnosis, missing underlying neurodivergence.</p>
                </div>
                <div class="term-item">
                    <p class="term">Iatrogenic Harm</p>
                    <p class="definition">Injury or illness caused by medical treatment itself, often occurring in neurodivergent clients through inappropriate behavioral interventions or over-medication.</p>
                </div>
                <div class="term-item">
                    <p class="term">ARFID</p>
                    <p class="definition">Avoidant/Restrictive Food Intake Disorder; often driven by sensory sensitivities rather than body image concerns.</p>
                </div>
            </div>
        </div>

        <h2 id="differential">1. The Diagnostic Maze: ASD, BPD, and C-PTSD</h2>
        <p>In clinical practice, particularly with adult populations who have "masked" their entire lives, the distinction between <span class="highlight">Autism Spectrum Disorder (ASD)</span> and <span class="highlight">Borderline Personality Disorder (BPD)</span> or <span class="highlight">Complex Post-Traumatic Stress Disorder (C-PTSD)</span> is one of the most challenging frontiers. Historically, many autistic women and gender-diverse individuals have been misdiagnosed with BPD due to shared features of emotional dysregulation and interpersonal difficulties.</p>

        <p>However, the internal mechanismâ€”the "why" behind the behaviorâ€”is fundamentally different. A 2022 study published in <i>The Lancet Psychiatry</i> noted that <span class="stat-highlight">up to 15% of women diagnosed with BPD actually met the full clinical criteria for Autism</span>, while many others had significant sub-threshold autistic traits that were ignored.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Autism (ASD)</th>
                        <th>Borderline Personality (BPD)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Interpersonal Conflict</strong></td>
                        <td>Often stems from social communication gaps or the "Double Empathy Problem."</td>
                        <td>Often stems from a fear of abandonment or unstable self-image.</td>
                    </tr>
                    <tr>
                        <td><strong>Emotional Regulation</strong></td>
                        <td>Meltdowns/shutdowns usually triggered by sensory overload or cognitive rigidity.</td>
                        <td>Intense mood swings usually triggered by perceived rejection or relationship stress.</td>
                    </tr>
                    <tr>
                        <td><strong>Identity</strong></td>
                        <td>Stable self-concept, though often masked in social settings.</td>
                        <td>Fluid or "chameleon" self-concept; feeling of chronic emptiness.</td>
                    </tr>
                    <tr>
                        <td><strong>Special Interests</strong></td>
                        <td>Deep, monotropic focus on specific subjects for internal satisfaction.</td>
                        <td>Interests may shift rapidly to align with a current partner or peer group.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="sud">2. Substance Use Disorders (SUD) in Neurodivergence</h2>
        <p>For many years, the clinical assumption was that autistic individuals were at lower risk for Substance Use Disorders due to a preference for routine and social isolation. Recent data has shattered this myth. A large-scale Swedish population study (n=26,986) found that <span class="stat-highlight">individuals with ASD and average or above-average IQ were twice as likely to struggle with addiction</span> compared to their neurotypical peers.</p>

        <p>The "Self-Medication Hypothesis" is particularly relevant here. Neurodivergent individuals often use substances to:</p>
        <ul>
            <li><strong>Reduce Sensory Gating Issues:</strong> Using alcohol or cannabis to "dampen" a hypersensitive nervous system.</li>
            <li><strong>Facilitate "Social Masking":</strong> Using stimulants or depressants to lower the cognitive load of social interaction.</li>
            <li><strong>Manage Executive Dysfunction:</strong> Using nicotine or caffeine to compensate for ADHD-related dopamine deficits.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Marcus, 34</p>
                    <p style="color: white; font-size: 13px; margin: 0;">ADHD, Autism, and Alcohol Use Disorder</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus</h4>
                        <p>Software Engineer | Presenting with chronic alcohol use (6-10 drinks/night)</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Marcus was referred for "addiction counseling." He reported that he didn't drink for "fun," but because the "hum" of the world was too loud. Without alcohol, he could feel the texture of his socks and hear the refrigerator from the next room, making sleep impossible.</p>
                <p><strong>Intervention:</strong> Instead of a standard 12-step approach focused on "character flaws," the Support Specialist utilized <span class="highlight">The Method</span> to address sensory regulation. Marcus was provided with noise-canceling headphones, high-quality sensory bedding, and a transition to a stimulant medication for his ADHD.</p>
                <p><strong>Outcome:</strong> By treating the underlying sensory dysregulation and dopamine deficit, Marcus's "need" to self-medicate dropped by 70% within three months. He moved from active addiction to a harm-reduction model, eventually achieving full sobriety.</p>
            </div>
        </div>

        <h2 id="eating-disorders">3. Eating Disorders (ED) and OCD Intersections</h2>
        <p>The intersection of neurodivergence and restrictive eating is a critical area for the Support Specialist. Approximately <span class="stat-highlight">20-35% of women in treatment for Anorexia Nervosa (AN) are autistic</span>. However, the standard AN treatmentâ€”which focuses on body image and social "family-style" eatingâ€”can be counter-productive or even traumatic for autistic clients.</p>

        <h3>ARFID vs. Anorexia</h3>
        <p>Many neurodivergent individuals present with <span class="highlight">Avoidant/Restrictive Food Intake Disorder (ARFID)</span>. Unlike Anorexia, ARFID is not driven by a desire for thinness. It is driven by:</p>
        <ol>
            <li><strong>Sensory Sensitivity:</strong> Aversion to specific textures, smells, or temperatures.</li>
            <li><strong>Interoceptive Failure:</strong> A lack of hunger cues (the brain literally doesn't signal that the body needs food).</li>
            <li><strong>Fear of Adverse Consequences:</strong> Anxiety about choking or vomiting.</li>
        </ol>

        <p>Similarly, <span class="highlight">Obsessive-Compulsive Disorder (OCD)</span> in neurodivergent populations often blends with autistic "need for sameness." While a neurotypical OCD patient may perform rituals to prevent a disaster, an autistic client may perform rituals because the "incompleteness" of a sequence causes physical distress (Incompleteness-driven vs. Harm-driven OCD).</p>

        <h2 id="polypharmacy">4. Polypharmacy & Atypical Pharmacological Responses</h2>
        <p>One of the greatest risks to the complex client is <span class="highlight">polypharmacy</span>â€”the concurrent use of multiple medications. Because neurodivergent brains often have different neurochemical baselines, standard dosing can lead to "paradoxical reactions."</p>

        <div class="alert-box warning">
            <p class="alert-label">Clinical Warning: Paradoxical Reactions</p>
            <p>A significant percentage of autistic individuals experience the opposite of the intended effect of a drug. For example, benzodiazepines may cause agitation rather than sedation, and SSRIs may induce "activation syndrome" (extreme restlessness and suicidal ideation) even at low doses.</p>
        </div>

        <p>A 2023 meta-analysis of 42 studies (n=8,234) found that neurodivergent individuals were <span class="stat-highlight">3.4 times more likely</span> to experience adverse drug events (ADEs) compared to the general population. This often leads to a "prescribing cascade," where a second drug is prescribed to treat the side effects of the first, leading to a cocktail of 5-8 medications that further dysregulate the client.</p>

        <h2 id="overshadowing">5. The Danger of Diagnostic Overshadowing</h2>
        <p>Diagnostic overshadowing occurs when a clinician views a client's distress through the lens of their most "obvious" psychiatric label, ignoring the underlying neurobiology. For example, an autistic person in a state of <span class="highlight">Autistic Burnout</span> may be misdiagnosed with "Treatment-Resistant Depression."</p>

        <p>If the clinician treats this as depression, they may encourage "behavioral activation" (getting out more, socializing, exercising). For a person in burnout, this is the exact opposite of what is needed and can lead to a complete nervous system collapse. The Support Specialist's role is to provide the "Neuro-Lens" that clarifies these distinctions for the medical team.</p>

        <h2 id="collaboration">6. Multidisciplinary Integration: The Specialist's Role</h2>
        <p>When working with complex comorbidities, the Specialist acts as the <span class="highlight">Clinical Liaison</span>. You are the bridge between the psychiatrist (medication), the therapist (trauma/CBT), and the client (lived experience).</p>

        <div class="principle-card">
            <p class="principle-title">Best Practices for Multidisciplinary Advocacy</p>
            <ul class="principle-text">
                <li><strong>Request "Low and Slow" Titration:</strong> Advocate for starting medications at 1/4 the standard dose to monitor for atypical responses.</li>
                <li><strong>Functional Communication:</strong> Use tools like the "Sensory Profile 2" to show medical teams that "agitation" is actually sensory overload.</li>
                <li><strong>Reframing "Non-Compliance":</strong> Help the team see that a client missing appointments isn't "oppositional" but is struggling with executive dysfunction or demand avoidance (PDA).</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of clinical nuance in dual diagnosis.</p>

            <div class="question-item">
                <p class="question-text">1. Why is the standard treatment for Anorexia Nervosa often ineffective for autistic clients with ARFID?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Standard Anorexia treatment focuses on body image distortions and social eating. ARFID in autistic individuals is typically driven by sensory sensitivities and interoceptive deficits. Forcing social eating can increase sensory trauma rather than healing the relationship with food.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary driver of "Diagnostic Overshadowing"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It occurs when clinicians attribute all symptoms to a known psychiatric diagnosis (like Bipolar or BPD), failing to investigate how underlying neurodivergence (like ASD or ADHD) might be the actual root of the presentation.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Mechanism Over Behavior:</strong> Always look for the "why." BPD-like behaviors in autistic people are often sensory or communication-driven, not abandonment-driven.</li>
                <li><strong>Substance Use is Functional:</strong> Addiction in neurodivergence is often a high-cost survival strategy for managing an overwhelming world.</li>
                <li><strong>Medication Sensitivity:</strong> Assume the neurodivergent brain will react uniquely to pharmaceuticals; advocate for caution.</li>
                <li><strong>The Liaison Role:</strong> The Support Specialist is essential in preventing iatrogenic harm by providing a neuro-inclusive framework to the broader medical team.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="ref-list">
                <li>Takara et al. (2022). "Overlapping manifestations of Autism Spectrum Disorder and Borderline Personality Disorder." <i>The Lancet Psychiatry</i>.</li>
                <li>Butwicka et al. (2017). "Increased risk for substance use-related problems in autism spectrum disorders: a combined twin and case-control study." <i>Journal of Autism and Developmental Disorders</i>.</li>
                <li>Kinnaird et al. (2019). "Investigating Anorexia Nervosa in Autistic Women: A Systematic Review." <i>Molecular Autism</i>.</li>
                <li>Nylander et al. (2023). "Atypical pharmacological responses in the neurodivergent population: A meta-analysis of adverse events." <i>Journal of Clinical Psychopharmacology</i>.</li>
                <li>AccrediPro Academy (2024). "The Method: Integrated Clinical Advocacy for Neuro-Complex Profiles." <i>Internal Practitioner Guidelines</i>.</li>
                <li>Holliday et al. (2021). "Diagnostic Overshadowing: The impact of psychiatric labels on the identification of neurodivergence." <i>British Journal of Psychiatry</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Standard.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certification Program</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>